Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors
Markets

Angle plc among winners as small caps fall

Medtech firm Angle plc was among the winners on a day where stocks were dragged lower by UK manufacturing data.....
parsortix_5535efa50ea0d.jpg
Angle's parsortix device.....

Medtech firm Angle plc (LON:AGL) was among the winners on a day where stocks were dragged lower by UK manufacturing data

Angle shares added almost 15% on the day to 81p as it revealed a potential breakthrough in the detection, monitoring and treatment of prostate cancer based on the results of a study by the Barts Cancer Institute (BCI).

The data, presented in a poster at an international cancer symposium, show that ANGLE’s Parsortix liquid biopsy not only detects the killer disease, the device also allows doctors assess how aggressive the cancer is.

It will now work with BCI and other leading cancer centres to develop and implement clinical studies to validate the use of the Parsortix system “in the routine detection, assessment and treatment of prostate cancer patients”.

Meanwhile, the biggest junior shares on FTSE AIM 100 were 0.18% down at 3,308, while the FTSE AIM all share was down 0.13% at 705.760.

FTSE100 was also lower, down 0.23% at 6,175 as the latest survey on UK manufacturing showed continued weakness. The CBI Industrial Trends survey said factory output fell at its fastest pace in more than six years.

Among the big losers in London  was Quadrise Fuels International PLC (LON:QFI), down 13.79% to 12.5p after its half-yearly report.

The provider of a low-cost alternative to fuel oil in the shipping, refining and power generation markets made a loss before tax in the second half of 2015 of £2.35mln, little changed from the loss of £2.21mln in the same period of 2014.

The company ended 2015 with cash reserves of £6.50 million, which it said should be sufficient to carry the group through to sustainable early revenues from its major projects, based on the current programme time scales.

Also lower was Brady (LON:BRY), which eased 9.73% to 51p despite the trading software supplier revealing that overheads were now much lower after it responded swiftly to the collapse in global commodity prices.

Market conditions were weaker than expected in the second half of last year, resulting in underlying earnings (EBITDA) before exceptional items falling to £2.5mln in 2015 from £2.5mln in 2014.

The company made a loss before tax and exceptional items of £928,000, versus a profit before tax and exceptional items the year before of £3.23mln.

Heading north, appropriately enough perhaps, was Namibia-focused mining project developer North River Resources PLC (LON:NRRP) as further drilling at its flagship Namib lead-zinc project hit high grade mineralisation.

The shares advanced almost 14% to stand at 0.08p each.

Giles_55af4ddca6481.jpg

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use